Type of Cancer
Genito-Urinary
Phase
Division (Location)
Study ID
NCT#
Brief Description
A single-arm, multicenter, Phase 2 trial to evaluate efficacy and safety of lenvatinib in combination with everolimus in subjects with unresectable advanced or metastatic non clear cell renal cell carcinoma (nccRCC) who have not received any chemotherapy for advanced disease
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.